Ocugen (OCGN) Enterprise Value (QoQ) (2014 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Ocugen | 452.01 Mn | 452.01 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 40.54% |
| Mar 31, 2024 | 33.10% |
| Dec 31, 2023 | 26.21% |
| Sep 30, 2023 | 24.23% |
| Jun 30, 2023 | 8.01% |
| Mar 31, 2023 | 15.63% |
| Dec 31, 2022 | 10.50% |
| Sep 30, 2022 | 11.65% |
| Jun 30, 2022 | 11.38% |
| Mar 31, 2022 | -36.66% |
| Dec 31, 2021 | 11.54% |
| Sep 30, 2021 | 7.17% |
| Jun 30, 2021 | -158.18% |
| Mar 31, 2021 | -86.33% |
| Dec 31, 2020 | -25.82% |
| Sep 30, 2020 | -27.65% |
| Jun 30, 2020 | -368.78% |
| Mar 31, 2020 | 57.11% |
| Dec 31, 2019 | 51.35% |
| Sep 30, 2019 | -2,155.16% |
| Jun 30, 2019 | -119.78% |
| Mar 31, 2019 | 81.04% |
| Dec 31, 2018 | 34.45% |
| Sep 30, 2018 | 71.69% |
| Jun 30, 2018 | 43.43% |
| Mar 31, 2018 | -94.30% |
| Dec 31, 2017 | 36.75% |
| Sep 30, 2017 | 31.94% |
| Jun 30, 2017 | 23.94% |
| Mar 31, 2017 | 23.61% |
| Dec 31, 2016 | 16.02% |
| Sep 30, 2016 | -138.57% |
| Jun 30, 2016 | 30.45% |
| Mar 31, 2016 | 25.94% |
| Dec 31, 2015 | 18.05% |
| Sep 30, 2015 | 16.58% |
| Jun 30, 2015 | 14.97% |
| Mar 31, 2015 | 9.13% |
| Dec 31, 2014 | -1,696.41% |
| Sep 30, 2014 | 58.10% |
| Jun 30, 2014 | -131.43% |